ArticleObesity surgery2020

Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic Syndrome.

Natascha Roehlen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.